OncoGenex Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 20.1 | 22.4 | 8.3 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 35.1 | 48.4 | 29.5 |
| Depreciation & Amortization | 0.3 | 0.3 | 0.6 |
| Operating Income | (15.2) | (26.3) | (21.8) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 2.2 | 2.7 | 0.7 |
| Nonoperating Expenses | 0.0 | 0.0 | 0.0 |
| Income Before Taxes | (13.1) | (23.5) | (21.1) |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | (13.1) | (23.5) | (21.1) |
| Continuing Operations | (13.1) | (23.5) | (21.1) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (13.1) | (23.5) | (21.1) |
| Total Net Income | (13.1) | (23.5) | (21.1) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.35) | (0.68) | (0.88) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
